Semax Peptide Pen - 10mg

Peptide Name

Semax (ACTH 4-7 Pro-Gly-Pro)

CAS Number

• CAS Registry Number: 80714-61-0

Research Areas of Focus

Researchers are actively investigating Semax across several key neurological and physiological domains, including:

• Neuroprotective Activity and Ischemic Stroke Recovery: Evaluating the peptide's capacity to preserve neuronal viability, reduce cerebral edema, and lower functional deficits in animal models of global and focal cerebral ischemia.

• Cognitive Optimization and Memory Consolidation: Studying its influence on learning behavior, cognitive processing, and task focus under conditions of severe hypoxia, fatigue, or neurological stress.

• BDNF and TrkB Pathway Regulation: Investigating how the compound modulates neurotrophic gene expression, specifically looking at how it upregulates Brain-Derived Neurotrophic Factor (BDNF) and its corresponding receptor, Tyrosine Kinase B (TrkB), in hippocampal tissue.

• Attenuation of Neuroinflammation and Excitotoxicity: Analyzing its ability to suppress nitric oxide overproduction, control pro-inflammatory cytokine cascades, and defend synaptic structures against glutamate-induced toxicity.

• Inhibition of Amyloid-Beta Aggregation: Exploring the peptide's protective role in neurodegenerative models, specifically its capacity to alter copper-induced amyloid-beta (A\beta) aggregation and disrupt the pathway of amyloid fibrillogenesis.

RESEARCH-USE NOTICE

This product is supplied by Biolabs for laboratory and research purposes only. It is not intended to diagnose, treat, cure, or prevent any medical condition and should not be used as a substitute for professional medical advice or treatment.

Any information provided is for general research, product identification, storage, and handling purposes only. The purchaser is responsible for using and storing the product appropriately and in accordance with applicable regulations.